Barron’s - USA (2020-09-28)

(Antfer) #1

M10 BARRON’S September 28, 2020


Research Reports


HowAnalystsSizeUpCompanies


These reports, excerpted and edited by Barron’s, were issued recently by investment and


researchfirms.Thereportsareasamplingofanalysts’thinking;theyshouldnotbeconsidered


theviewsorrecommendationsofBarron’s.Someofthereports’issuershaveprovided,orhope


toprovide,investment-bankingorotherservicestothecompaniesbeinganalyzed.


To be considered for this section, material


should be sent to [email protected].


Nike• NKE-NYSE


Buy • Price $116.87 on Sept 23


by Guggenheim


Nike reported strong fiscal first-quarter


results, with earnings per share nearly two


times our expectation (95 cents versus 51


cents). Under the leadership of CEO John


Donahoe, Nike is rapidly embarking on the


next era of its history; this will be digitally


led and likely be defined by even greater


separation versus industry peers, as well


as from Nike’s own historical rates of pro-


ductivity, consumer engagement, and finan-


cial performance. Overall, our investment


thesis on NKE was further reinforced by


the results and strategy put forth by the


company last night. We are raising our es-


timates and price target ($165 from $150).


Nike remains our Best Idea.


Enterprise Products• EPD NYSE


Strong Buy • Price $15.33 on Sept. 24


by Raymond James


Enterprise [a natural-gas and oil pipeline


company] has not been immune to the head-


winds plaguing the broader midstream sec-


tor. However, EPD’s unique combination of


integration, strong balance sheet, and re-


turn on invested capital record remains


among the very best in class. We see Enter-


prise as arguably best positioned in its


space to withstand the volatile macro land-


scape. Moreover, it trades at an attractive


(and safe) 11.5% yield and heavily histori-


cally discounted eight times 2021 enterprise


value/Ebitda [earnings before interest,


taxes, depreciation, and amortization]. We


reiterate our $25 target price, based on our


2021 valuation.


Union Pacific• UNP- NYSE


Buy • Price of $194.32 on Sept. 24


by Benchmark


We maintain our Buy rating on Union Pa-


cific and raise our price target from $190 to


$220. Our target assumes that the shares


are valued at 23 times our 2021 estimate


and 20 times our 2022 forecast. On a rela-


tive basis, UNP trades at a 5% premium to


the one-year forward S&P market multiple.


On a 2021 estimated free-cash-flow basis,


we have Union Pacific trading at 4.3%,


slightly above its peers.


Due to its successful implementation of


precision scheduled railroading, UNP is not


only better positioned to withstand eco-


nomic shocks like the current one, but also


to benefit over the long term. Coming out of


this recession, we look for better incremen-


tal margins/free-cash-flow conversion.


By 2022, we think Union Pacific can earn


anywhere from $10.20 to $11. At $11 of EPS


and an undiscounted 20 multiple, UNP


would be worth $220.


Goldman Sachs• GS-NYSE


Buy • Price $186.18 on Sept. 23


by UBS


Goldman is generating solid results in the


current environment, and potential volatility


from the coming U.S. election could allow


for a solid fourth quarter, bridging to first-


quarter seasonal strength. Furthermore, in


2021 we expect the efficiency efforts from


GS’s strategic plans to begin to impact its


profit-and-loss line, leading to upside to


earnings forecasts.


We see a path to 12%-plus returns on tan-


gible equity, yet Goldman is trading below


tangible book value. M&A announcements


are beginning to pick up, underwriting re-


sults have been very robust, and trading


volume and investor engagement has re-


mained elevated, all of which play to Gold-


man’s traditional strengths. As some of


these revenues recover (while trading nor-


malizes), Goldman’s efficiency efforts should


limit expense growth.


We are raising our 2020 EPS estimate by


16%, to $14.80, driven by expected strength


in trading, and our 2021 EPS estimate by


5%, to $24.50, on improved expense disci-


pline. We also are raising our price target to


$245, from $220. This applies a 10 times


multiple (previously 9.5 times) on our up-


dated 2021 EPS estimate.


WesBanco• WSBC-Nasdaq


Outperform/Moderate Risk • Price: $19.60


on Sept. 24


by Boenning & Scattergood


We are resuming coverage of WesBanco,


with a $27.50 price target, based on approxi-


mately 1.3 times tangible book and 11 times


price-to-normalized earnings.


WesBanco is the parent company of Wes-


Banco Bank, which operates 237 branches


in Indiana, Kentucky, Maryland, Ohio, Penn-


sylvania, and West Virginia. It had over


$16.8 billion in assets as of June 30, and


over $10.9 billion in loans. We believe


WSBC’s discounted valuation of 0.93 times


tangible book, versus peer average at 1.03


times, is unwarranted. We also believe that


WSBC’s strong deposit base is being


largely overlooked. Furthermore, its strong


capital level provides sufficient cushion in


the event of a more severe credit downturn.


Our Outperform rating is driven by these


attributes and valuation, where we see


nearly 25% upside to our target price.


We would potentially look to downgrade


this name upon its approaching our price


target, or if credit worsens materially from


our forecast. We are also monitoring Wes-


Banco’s hotel portfolio, which comprises 7%


of its total loans, for additional signs of


stress, given Covid-19’s impact on travel.


INSIDER TRANSACTIONS RATIO


0


10


20


30


40


50


60


O N D J F M A M J J AS


Ratio of Insiders Sales to Buys. Readings under 12:1 are Bullish. Those over 20:1 are Bearish.


The total top20 sales and buys are 587, 687 ,126 and 95, 295 ,357 respectively; Source: Thomson Reuters


Bearish


Bullish Ratio = 6


INSIDER TRANSACTIONS: Recent Filings


Purchases


$ Val
Company/Symbol Insiders Shares (000's)

Metacrine MTCR 12 7,613,070 76,892
Stepstone STEP 8 222,157 5,554

TravelcentersOfAmerica TA 1 104,738 2,259
CassavaSciences SAVA 2 262,000 1,900

OutsetMedical OM 3 23,500 1,411

AvadelPharmaceuticals AVDL 3 192,000 1,108
PactivEvergreen PTVE 3 76,342 1,039
VoxxInternational VOXX 1 97,042 756

KingswayFinancial KFS 4 240,288 743

CbFinancialServices CBFV 2 25,858 493

EntercomCommunications ETM 2 285,108 403

OfgBancorp OFG 2 31,152 397
HighwoodsProperties HIW 1 10,000 337

Cryolife CRY 2 20,000 333

ArlingtonAssetInvestment AI 2 120,000 321

Weyerhaeuser WY 1 10,000 291

LibertyLatinAmericaLtd LILA 2 35,000 290
ChathamLodgingTrust CLDT 1 32,600 265
Vereit VER 1 40,000 253

SaulCenters BFS 1 10,000 249

Sales


$ Val
Company/Symbol Insiders Shares (000's)

JfrogLimited FROG 3 1,438,000 93,154
BrighamMinerals MNRL 2 10,915,540 88,165
Knight-SwiftTransportation KNX 2 1,067,885 43,739

Paylocity PCTY 1 275,328 40,630

Schrodinger SDGR 2 593,889 31,517

Square SQ 1 200,000 30,786

PelotonInteractive PTON 2 333,500 27,017
Beigene BGNE 2 85,228 21,629

BroadridgeFinancialSolutions BR 1 153,438 20,741

OnewaterMarine ONEW 7 1,044,565 19,847

CoupaSoftware COUP 4 78,523 19,242

RaptTherapeutics RAPT 1 608,000 18,757
BeyondMeat BYND 1 127,500 18,464
Workday WDAY 2 86,094 17,919

Q2 QTWO 2 201,025 17,739

Stamps.Com STMP 2 76,319 16,629
Netflix NFLX 1 34,853 16,614

Zscaler ZS 5 120,991 15,942
Okta OKTA 5 75,719 14,752

Docusign DOCU 3 74,298 14,404

Aninsiderisanyofficer,directororownerof10%ormoreofaclassofacompany'ssecurities.Inmostcases,aninsidermustreportanytradeto
theSECwithintwobusinessdays.ThetableshighlightcompaniesthatfiledwiththeSECthroughlastWednesday.Thetablesdonotinclude
pension-planoremployeestock-optionactivity,tradesbybeneficialownersof10%ormore,tradesunder$2pershareortradesunder100
shares.The"Purchases"columnincludesonlyopen-marketandprivatepurchases;the"Sales"columnincludesonlyopen-marketandprivatesales,
andexcludestradesprecededbyoptionexerciseinthe12monthspriortothereportedevent. Source:ThomsonReuters
Free download pdf